» Articles » PMID: 35975998

Characterization of Macrophage-Tropic HIV-1 Infection of Central Nervous System Cells and the Influence of Inflammation

Overview
Journal J Virol
Date 2022 Aug 17
PMID 35975998
Authors
Affiliations
Soon will be listed here.
Abstract

HIV-1 infection within the central nervous system (CNS) includes evolution of the virus, damaging inflammatory cascades, and the involvement of multiple cell types; however, our understanding of how Env tropism and inflammation can influence CNS infectivity is incomplete. In this study, we utilize macrophage-tropic and T cell-tropic HIV-1 Env proteins to establish accurate infection profiles for multiple CNS cells under basal and interferon alpha (IFN-α) or lipopolysaccharide (LPS)-induced inflammatory states. We found that macrophage-tropic viruses confer entry advantages in primary myeloid cells, including monocyte-derived macrophage, microglia, and induced pluripotent stem cell (iPSC)-derived microglia. However, neither macrophage-tropic or T cell-tropic HIV-1 Env proteins could mediate infection of astrocytes or neurons, and infection was not potentiated by induction of an inflammatory state in these cells. Additionally, we found that IFN-α and LPS restricted replication in myeloid cells, and IFN-α treatment prior to infection with vesicular stomatitis virus G protein (VSV G) Envs resulted in a conserved antiviral response across all CNS cell types. Further, using RNA sequencing (RNA-seq), we found that only myeloid cells express HIV-1 entry receptor/coreceptor transcripts at a significant level and that these transcripts in select cell types responded only modestly to inflammatory signals. We profiled the transcriptional response of multiple CNS cells to inflammation and found 57 IFN-induced genes that were differentially expressed across all cell types. Taken together, these data focus attention on the cells in the CNS that are truly permissive to HIV-1, further highlight the role of HIV-1 Env evolution in mediating infection in the CNS, and point to limitations in using model cell types versus primary cells to explore features of virus-host interaction. The major feature of HIV-1 pathogenesis is the induction of an immunodeficient state in the face of an enhanced state of inflammation. However, for many of those infected, there can be an impact on the central nervous system (CNS) resulting in a wide range of neurocognitive defects. Here, we use a highly sensitive and quantitative assay for viral infectivity to explore primary and model cell types of the brain for their susceptibility to infection using viral entry proteins derived from the CNS. In addition, we examine the ability of an inflammatory state to alter infectivity of these cells. We find that myeloid cells are the only cell types in the CNS that can be infected and that induction of an inflammatory state negatively impacts viral infection across all cell types.

Citing Articles

The Impact of HIV on Early Brain Aging-A Pathophysiological (Re)View.

Lazar M, Moroti R, Barbu E, Chitu-Tisu C, Tiliscan C, Erculescu T J Clin Med. 2024; 13(23).

PMID: 39685490 PMC: 11642420. DOI: 10.3390/jcm13237031.


Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.

Hu Z, Cinque P, Dravid A, Hagberg L, Yilmaz A, Zetterberg H PLoS Pathog. 2024; 20(9):e1012470.

PMID: 39316609 PMC: 11469498. DOI: 10.1371/journal.ppat.1012470.


In situ analysis of neuronal injury and neuroinflammation during HIV-1 infection.

Honeycutt J, Wahl A, Files J, League A, Yadav-Samudrala B, Garcia J Retrovirology. 2024; 21(1):11.

PMID: 38945996 PMC: 11215835. DOI: 10.1186/s12977-024-00644-z.


Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4 T-cells.

Gumbs S, Stam A, Mudrikova T, Schipper P, Hoepelman A, van Ham P J Neurovirol. 2024; 30(4):380-392.

PMID: 38713307 PMC: 11512886. DOI: 10.1007/s13365-024-01207-w.


Sustained type I interferon signaling after human immunodeficiency virus type 1 infection of human iPSC derived microglia and cerebral organoids.

Boreland A, Stillitano A, Lin H, Abbo Y, Hart R, Jiang P iScience. 2024; 27(5):109628.

PMID: 38628961 PMC: 11019286. DOI: 10.1016/j.isci.2024.109628.


References
1.
Bagasra O, Khalili K, Seshamma T, Taylor J, Pomerantz R . TAR-independent replication of human immunodeficiency virus type 1 in glial cells. J Virol. 1992; 66(12):7522-8. PMC: 240462. DOI: 10.1128/JVI.66.12.7522-7528.1992. View

2.
Gumbs S, Kubler R, Gharu L, Schipper P, Borst A, Snijders G . Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses. J Neurovirol. 2022; 28(1):64-91. PMC: 9076745. DOI: 10.1007/s13365-021-01049-w. View

3.
Burdo T, Lackner A, Williams K . Monocyte/macrophages and their role in HIV neuropathogenesis. Immunol Rev. 2013; 254(1):102-13. PMC: 3704190. DOI: 10.1111/imr.12068. View

4.
Ko A, Kang G, Hattler J, Galadima H, Zhang J, Li Q . Macrophages but not Astrocytes Harbor HIV DNA in the Brains of HIV-1-Infected Aviremic Individuals on Suppressive Antiretroviral Therapy. J Neuroimmune Pharmacol. 2018; 14(1):110-119. PMC: 6391194. DOI: 10.1007/s11481-018-9809-2. View

5.
Saito Y, Sharer L, Epstein L, Michaels J, Mintz M, Louder M . Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology. 1994; 44(3 Pt 1):474-81. DOI: 10.1212/wnl.44.3_part_1.474. View